Logo image of ASTH

ASTRANA HEALTH INC (ASTH) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ASTH - US03763A2078 - Common Stock

22.5 USD
+2.16 (+10.62%)
Last: 11/21/2025, 8:12:38 PM
22.4982 USD
0 (-0.01%)
After Hours: 11/21/2025, 8:12:38 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
ASTH revenue by date.ASTH revenue by date.
1.144B
47.84%
1.387B
21.19%
2.035B
46.72%
3.273B
60.87%
4.158B
27.04%
4.567B
9.84%
4.778B
4.62%
5.149B
7.76%
5.547B
7.73%
5.971B
7.64%
EBITDA
YoY % growth
ASTH ebitda by date.ASTH ebitda by date.
121.808M
5.28%
102.361M
-15.97%
117.277M
14.57%
224.23M
91.20%
290.76M
29.67%
337.7M
16.14%
387.6M
14.78%
437.58M
12.89%
493.68M
12.82%
555.9M
12.60%
EBIT
YoY % growth
ASTH ebit by date.ASTH ebit by date.
104.265M
6.20%
84.613M
-18.85%
89.35M
5.60%
130.4M
45.94%
205.78M
57.81%
248M
20.52%
268.26M
8.17%
313.14M
16.73%
363.12M
15.96%
417.18M
14.89%
Operating Margin
ASTH operating margin by date.ASTH operating margin by date.
9.11%6.10%4.39%3.98%4.95%5.43%5.61%6.08%6.55%6.99%
EPS
YoY % growth
ASTH eps by date.ASTH eps by date.
1.06
-32.48%
1.32
24.53%
0.89
-32.58%
1.22
37.27%
2.08
70.32%
2.74
31.62%
3.05
11.36%
3.55
16.39%
4.03
13.51%
4.55
12.91%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.33
321.48%
0.44
217.66%
0.48
152.32%
0.67
6,591.20%
0.67
101.81%
0.56
25.46%
0.64
33.40%
0.64
-4.73%
0.64
-4.01%
Revenue
Q2Q % growth
965.42M
45.13%
964.35M
55.44%
996.52M
52.19%
1.028B
7.53%
1.104B
14.35%
1.024B
6.19%
1.055B
5.87%
1.035B
0.68%
1.047B
-5.16%
EBITDA
Q2Q % growth
57.789M
101.73%
67.737M
146.93%
73.424M
115.37%
74.365M
18.31%
75.398M
30.47%
68.645M
1.34%
73.769M
0.47%
73.463M
-1.21%
73.205M
-2.91%
EBIT
Q2Q % growth
37.017M
5,041.25%
42.692M
107.41%
45.128M
121.87%
53.504M
59.67%
59.063M
59.56%
24.259M
-43.18%
30.932M
-31.46%
31.773M
-40.62%
33.16M
-43.86%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.01
-96.97%
0.45-0.44-97.78%
Q2 2025
Q2Q % growth
0.19
-52.50%
0.37-0.18-48.70%
Q1 2025
Q2Q % growth
0.14
-54.84%
0.25-0.11-44.39%
Q4 2024
Q2Q % growth
-0.15
-157.69%
0.12-0.27-225.16%
Q3 2024
Q2Q % growth
0.33
-29.79%
0.320.011.74%
Q2 2024
Q2Q % growth
0.40
42.86%
0.400.000.55%
Q1 2024
Q2Q % growth
0.31 0.310.000.75%
Q4 2023
Q2Q % growth
0.26
533.33%
0.150.1171.85%
Q3 2023
Q2Q % growth
0.47
-16.07%
0.340.1339.63%
Q2 2023
Q2Q % growth
0.28
12.00%
0.260.039.80%
Q1 2023
Q2Q % growth
0.31 0.310.00-0.90%
Q4 2022
Q2Q % growth
-0.06
-120.00%
-0.090.0334.64%
Q3 2022
Q2Q % growth
0.56
-18.84%
0.320.2472.38%
Q2 2022
Q2Q % growth
0.25
-10.71%
0.210.0420.74%
Q1 2022
Q2Q % growth
0.31
3.33%
0.33-0.02-5.02%
Q4 2021
Q2Q % growth
0.30
11.11%
0.270.0310.99%
Q3 2021
Q2Q % growth
0.69
53.33%
0.350.3498.96%
Q2 2021
Q2Q % growth
0.28
116.00%
0.210.0730.72%
Q1 2021
Q2Q % growth
0.30
172.73%
0.220.0833.69%
Q4 2020
Q2Q % growth
0.27
50.00%
0.180.0947.06%
Q3 2020
Q2Q % growth
0.45
350.00%
0.220.23100.53%
Q2 2020
Q2Q % growth
-1.75
-2,044.44%
0.07-1.82-2,550.98%
Q1 2020
Q2Q % growth
0.11 0.040.07169.61%
Q4 2019
Q2Q % growth
0.18 0.20-0.02-11.76%
Q3 2019
Q2Q % growth
0.10 0.14-0.04-29.97%
Q2 2019
Q2Q % growth
0.09 0.050.0476.47%
Q1 2019
Q2Q % growth
0.00 0.08-0.08-100.00%
ASTH Yearly EPS VS EstimatesASTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2 3 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
956.048M
99.71%
971.84M-15.792M-1.62%
Q2 2025
Q2Q % growth
654.808M
34.66%
651.09M3.718M0.57%
Q1 2025
Q2Q % growth
620.39M
53.43%
643.29M-22.9M-3.56%
Q4 2024
Q2Q % growth
665.209M
88.43%
629.59M35.619M5.66%
Q3 2024
Q2Q % growth
478.71M
37.49%
471.62M7.09M1.50%
Q2 2024
Q2Q % growth
486.265M
39.65%
449.57M36.695M8.16%
Q1 2024
Q2Q % growth
404.356M
19.90%
422.13M-17.774M-4.21%
Q4 2023
Q2Q % growth
353.036M
40.79%
347.99M5.046M1.45%
Q3 2023
Q2Q % growth
348.173M
26.61%
357.1M-8.927M-2.50%
Q2 2023
Q2Q % growth
348.209M 348.81M-601K-0.17%
Q1 2023
Q2Q % growth
337.244M 324.43M12.814M3.95%
Q4 2022
Q2Q % growth

41.09%
250.76M%
Q3 2022
Q2Q % growth

51.46%
274.99M%
Q4 2021
Q2Q % growth

5.92%
177.73M%
Q3 2021
Q2Q % growth

6.39%
181.56M%
Q2 2021
Q2Q % growth

4.65%
174.32M%
Q1 2021
Q2Q % growth

3.33%
175.17M%
Q4 2020
Q2Q % growth

7.03%
167.79M%
Q3 2020
Q2Q % growth

1.20%
170.65M%
Q2 2020
Q2Q % growth

22.83%
166.57M%
Q1 2020
Q2Q % growth

26.39%
169.52M%
ASTH Yearly Revenue VS EstimatesASTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-24.47% -29.06% 0% -6.99%
Revenue-3.75% -3.65% 0% 0.06%